Listed

AbbVie Inc.

ABBVNYSECIK 1551152HealthcareFiscal year ends Dec 31

Reports and events: 278 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

AbbVie Inc., Reports and events
FiledFormWhat it isAccession number
2024-05-0817:00 ET8-K/A5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0001104659-24-058808
2024-05-0311:04 ET10-QQuarterly reportPeriod 2024-03-310001551152-24-000020
2024-04-2607:43 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001551152-24-000016
2024-04-0316:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001551152-24-000013
2024-03-1816:15 ETDEF 14AProxy statementPeriod 2024-05-030001558370-24-003496
2024-02-2617:08 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-24-027585
2024-02-2012:45 ET10-KAnnual reportPeriod 2023-12-310001551152-24-000011
2024-02-2009:00 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-24-025262
2024-02-1207:49 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-24-013692
2024-02-0207:51 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001551152-24-000007
2024-01-0516:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001551152-24-000002
2023-12-0617:28 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-23-124047
2023-11-3008:47 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-23-122241
2023-11-0613:01 ET10-QQuarterly reportPeriod 2023-09-300001551152-23-000045
2023-10-2707:49 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001551152-23-000040
2023-10-1217:17 ET8-K5.02 Departure or appointment of officers or directors0001104659-23-108864
2023-10-0416:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001551152-23-000036
2023-08-0713:10 ET10-QQuarterly reportPeriod 2023-06-300001551152-23-000033
2023-07-2707:45 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001551152-23-000028
2023-07-0616:18 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001551152-23-000026
2023-06-2917:00 ET8-K5.02 Departure or appointment of officers or directors0001104659-23-076373
2023-05-1017:10 ET8-K5.07 Shareholder vote results0001104659-23-058520
2023-05-0512:54 ET10-QQuarterly reportPeriod 2023-03-310001551152-23-000023
2023-04-2707:36 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001551152-23-000019
2023-04-0516:33 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001551152-23-000015
2023-03-2816:37 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001104659-23-037749
2023-03-2017:00 ETDEF 14AProxy statement0001558370-23-004204
2023-02-1712:54 ET10-KAnnual reportPeriod 2022-12-310001551152-23-000011
2023-02-0907:55 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001551152-23-000006
2023-01-1008:15 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-23-002452
2023-01-0616:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001551152-23-000004
2022-11-2909:01 ET8-K5.02 Departure or appointment of officers or directors0001104659-22-122661
2022-11-0413:07 ET10-QQuarterly reportPeriod 2022-09-300001551152-22-000045
2022-10-2807:48 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001551152-22-000038
2022-10-1709:05 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-22-109061
2022-10-1417:02 ET8-K5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001104659-22-108910
2022-10-0516:14 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001551152-22-000034
2022-08-0415:57 ET10-QQuarterly reportPeriod 2022-06-300001551152-22-000030
2022-07-2907:49 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001551152-22-000026
2022-07-0616:17 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001551152-22-000023
2022-06-2908:30 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001104659-22-075519
2022-06-2809:16 ET8-K5.02 Departure or appointment of officers or directors0001104659-22-075039
2022-05-1117:06 ET8-K5.07 Shareholder vote results0001104659-22-058862
2022-05-0612:51 ET10-QQuarterly reportPeriod 2022-03-310001551152-22-000017
2022-04-2909:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001551152-22-000012
2022-04-2907:45 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001551152-22-000010
2022-04-2117:12 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-22-048450
2022-04-1309:15 ET8-K5.02 Departure or appointment of officers or directors0001104659-22-045308
2022-03-2117:00 ETDEF 14AProxy statementPeriod 2022-05-060001558370-22-004011
2022-03-0416:16 ET8-K5.02 Departure or appointment of officers or directors0001104659-22-030613

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:34 ET. Listed shows no prices and gives no investment advice.